The purpose of this study was to evaluate initially the response and toxicities of Gemcitabine-Cisplatin induction chemotherapy with stage III - IVA nasopharyngeal carcinoma (NPC) at Nghe an Oncology Hospital from 1/2020 to 3/2022.